Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+7.34%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
9.5%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$125M |
| 2 |
Apple
AAPL
|
$107M |
| 3 |
Microsoft
MSFT
|
$100M |
| 4 |
FedEx
FDX
|
$95.2M |
| 5 |
Fidelity National Information Services
FIS
|
$90M |
Top Sells
| 1 |
Booking.com
BKNG
|
$100M |
| 2 |
Cigna
CI
|
$97.2M |
| 3 |
Phillips 66
PSX
|
$84.3M |
| 4 |
Gilead Sciences
GILD
|
$80.1M |
| 5 |
Snowflake
SNOW
|
$51.2M |
Sector Composition
| 1 | Technology | 26.39% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
First Savings Financial Group
FSFG
$189M
| $214K | ﹤0.01% |
10,677
-6,465
| -38% | -$129K |
|
902
Root
ROOT
$1.43B
| $209K | ﹤0.01% |
46,627
-2,704
| -5% | -$12.1K |
|
903
Werewolf Therapeutics
HOWL
$61.7M
| $208K | ﹤0.01% |
+101,221
| New | +$208K |
|
904
Exelon
EXC
$43.9B
| $206K | ﹤0.01% |
+4,775
| New | +$206K |
|
905
Greenlight Captial
GLRE
$436M
| $206K | ﹤0.01% |
25,290
-38,091
| -60% | -$310K |
|
906
Business First Bancshares
BFST
$745M
| $204K | ﹤0.01% |
9,234
-431
| -4% | -$9.54K |
|
907
Biglari Holdings Class B
BH
$966M
| $201K | ﹤0.01% |
+1,451
| New | +$201K |
|
908
American Realty Investors
ARL
$256M
| $201K | ﹤0.01% |
+7,844
| New | +$201K |
|
909
Bank of N.T. Butterfield & Son
NTB
$1.86B
| $200K | ﹤0.01% |
6,721
-23
| -0.3% | -$686 |
|
910
Cue Biopharma
CUE
$59.9M
| $198K | ﹤0.01% |
+69,522
| New | +$198K |
|
911
Tenaya Therapeutics
TNYA
$220M
| $196K | ﹤0.01% |
97,631
-159,004
| -62% | -$320K |
|
912
KVH Industries
KVHI
$116M
| $191K | ﹤0.01% |
18,642
-53,650
| -74% | -$548K |
|
913
Rapid Micro Biosystems
RPID
$120M
| $182K | ﹤0.01% |
+161,400
| New | +$182K |
|
914
Caesarstone
CSTE
$48.7M
| $179K | ﹤0.01% |
+31,303
| New | +$179K |
|
915
Lands' End
LE
$439M
| $166K | ﹤0.01% |
+21,900
| New | +$166K |
|
916
Aldeyra Therapeutics
ALDX
$334M
| $149K | ﹤0.01% |
21,374
-260,462
| -92% | -$1.81M |
|
917
Noodles & Co
NDLS
$31.1M
| $149K | ﹤0.01% |
27,085
-5,581
| -17% | -$30.6K |
|
918
American Outdoor Brands
AOUT
$109M
| $146K | ﹤0.01% |
14,620
-113,825
| -89% | -$1.14M |
|
|
HRT
919
DELISTED
HireRight Holdings Corporation
HRT
| $144K | ﹤0.01% |
+12,143
| New | +$144K |
|
920
Vaalco Energy
EGY
$399M
| $137K | ﹤0.01% |
30,112
-100,900
| -77% | -$460K |
|
921
Editas Medicine
EDIT
$248M
| $134K | ﹤0.01% |
15,103
-92,035
| -86% | -$816K |
|
922
CCC Intelligent Solutions
CCCS
$6.4B
| $131K | ﹤0.01% |
15,007
-555,818
| -97% | -$4.84M |
|
923
Olema Pharmaceuticals
OLMA
$570M
| $127K | ﹤0.01% |
51,828
-28,091
| -35% | -$68.8K |
|
924
Cooper-Standard Automotive
CPS
$677M
| $122K | ﹤0.01% |
13,508
-89,084
| -87% | -$807K |
|
925
Verastem
VSTM
$663M
| $118K | ﹤0.01% |
24,361
-7,199
| -23% | -$34.8K |
|